The FDA real-time clinical trial model enables prospective safety monitoring, improving risk assessment and speeding oncology drug development.
Despite increasing use of artificial intelligence (AI) in health care, a new study led by Mass General Brigham researchers from the MESH Incubator shows that generative AI models continue to fall ...
Large Language Models (LLMs) such as GPT-4, Gemini-Pro, Llama 2, and medical-domain-tuned variants like Med-PaLM 2 have demonstrated remarkable capabilities in answering medical questions and clinical ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results